COVID-19 News & Education

The latest news, research, and COVID-19 testing information from Labcorp

Latest articles from our blog

COVID-19 vs. Flu vs. RSV

COVID-19 vs. Flu vs. RSV: How to tell the difference between respiratory infections

Learn the differences between the flu, COVID-19, and RSV and ways to diagnose them.

A Guide to the COVID-19 Variants

A Guide to the COVID-19 Variants: What You Need to Know About Testing and More

Learn about the multiple SARS-CoV-2 variants that have emerged since the start of the pandemic.

COVID-19 Testing For Small Businesses

A Guide To COVID-19 Testing For Small Businesses

Helping your business get back to work safely.

COVID-19 Testing Differences

COVID-19 Testing Options to Detect Current Infection vs. Prior Infection

Get a better understanding of COVID-19 testing options – from what each type of test actually detects to sample collection and results. Know the facts to determine what’s best for you.

COVID-19 News

Jul 1 2021

Labcorp Extends COVID-19 Genomic Sequencing Work With The CDC

BURLINGTON, N.C., June 30, 2021 — Labcorp (NYSE: LH), a leading global life sciences company, today announced the extension of its work with the U.S. Centers for Disease Control and Prevention (CDC) to help identify and monitor variants of SARS-CoV-2, the virus that causes COVID-19. 

Read more »

View our latest news about advancements in health science, COVID-19, and more.

View more COVID-19 News

Labcorp's COVID-19 PCR Testing

1-2 Days

Average Time to Result from Specimen Pickup

45M

Molecular tests performed

275K

Molecular test capacity per day**

5.5M

Antibody tests performed

300K

Antibody test  capacity per day**

$0

Tests Offered with No Upfront Costs*

Tracking COVID-19 Variants

We have been regularly tracking variants of the virus throughout the pandemic. The sensitivity of our PCR test is not impacted by these variants.

Labcorp PCR Test Performance Confirmed

Checkmark
Variant B.1.1.7 (Alpha, Common name: U.K. Variant)
Checkmark
Variant B.1.351 (Beta Common name: South Africa Variant)
Checkmark
Variant P.1 (Gamma, Common name: Brazil Variant)
Checkmark
Variant B.1.526 (Iota, Common name: New York Variant)
Checkmark
Variant B.1.617.2 (Delta, Common name: India Variant)
Checkmark
Variant C.37 (Lambda, Common name: Peru Variant)

Labcorp has been working with the Centers for Disease Control and Prevention (CDC) to provide sequencing of samples of SARS-CoV-2, the virus that causes COVID-19.

For more information visit US COVID-19 Cases Caused by Variants on the CDC website. 

Scroll back to top of page